Journal profile · CLINICAL NEUROLOGY
Neurodegenerative Disease Management
ISSN 1758-2024 · eISSN 1758-2032 · Future Medicine Ltd.
Neurodegenerative Disease Management: CAS Zone 4 · Medicine (2025 upgraded edition); hybrid open access; median 122 days to acceptance (105 articles, last 24 months); 85 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Neurodegenerative Disease Management is published by Future Medicine Ltd. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Dementia and Cognitive Impairment Research, Parkinson's Disease Mechanisms and Treatments and Multiple Sclerosis Research Studies, together about 43.2% of its articles. Its main subfields are Neurology. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): CLINICAL NEUROLOGY
Main research topics OpenAlex counts of recent articles; shares are approximate
- Dementia and Cognitive Impairment ResearchMedicine18.4%
- Parkinson's Disease Mechanisms and TreatmentsMedicine13.7%
- Multiple Sclerosis Research StudiesMedicine11.2%
- Alzheimer's disease research and treatmentsMedicine10.9%
- Neurological disorders and treatmentsMedicine7.7%
- Amyotrophic Lateral Sclerosis ResearchMedicine5.1%
- Genetic Neurodegenerative DiseasesNeuroscience3%
- Balance, Gait, and Falls PreventionHealth Professions2.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Neurology (clinical) | Q2 | 142/403 | 64th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 4.7LetPub ·
- SJR 2026-06
- 0.8LetPub ·
- SNIP 2026-06
- 0.81LetPub ·
- h-index
- 47OpenAlex ·
- i10-index
- 292OpenAlex ·
- 2-year mean citedness
- 1.89OpenAlex ·
- Self-citation rate
- 3.6%LetPub ·
- Share of gold OA articles
- 12.93%LetPub ·
Volume
- Articles per year
- 73LetPub ·
Articles by year OpenAlex count · 902 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 75 | 28 | 995 |
| 2025 | 85 | 83 | 1,174 |
| 2024 | 26 | 25 | 1,317 |
| 2023 | 27 | 11 | 1,165 |
| 2022 | 34 | 25 | 1,147 |
| 2021 | 38 | 16 | 1,164 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
122 daysMedian, submission to acceptance · P25–P75 93 days – 166 days
- Acceptance to online
- median 12 days (105 articles)
- Submission to online
- median 142 days
- Sample
- 105 articles with submission and acceptance dates (156 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Future Medicine Ltd.
- ISSN
- 1758-2024
- Electronic ISSN
- 1758-2032
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about Neurodegenerative Disease Management
What CAS zone is Neurodegenerative Disease Management in?
In the 2025 upgraded edition of the CAS Journal Ranking, Neurodegenerative Disease Management is in Zone 4 of Medicine, and in Zone 4 of the minor category Clinical Neurology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Neurodegenerative Disease Management?
Based on the dates recorded on 105 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 122 days (interquartile range 93–166 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Neurodegenerative Disease Management?
According to LetPub and DOAJ records, Neurodegenerative Disease Management is indexed in ESCI and Scopus.
Is Neurodegenerative Disease Management open access, and what is the APC?
Neurodegenerative Disease Management is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .